Thrivent Financial for Lutherans’s Maravai LifeSciences MRVI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-214,645
| Closed | -$1.78M | – | 2584 |
|
|
2024
Q3 | $1.78M | Buy |
214,645
+26,885
| +14% | +$223K | ﹤0.01% | 1529 |
|
|
2024
Q2 | $1.34M | Buy |
187,760
+11,874
| +7% | +$85K | ﹤0.01% | 1659 |
|
|
2024
Q1 | $1.53M | Sell |
175,886
-125,009
| -42% | -$1.08M | ﹤0.01% | 1618 |
|
|
2023
Q4 | $1.97M | Sell |
300,895
-11,537,474
| -97% | -$75.6M | ﹤0.01% | 1378 |
|
|
2023
Q3 | $118M | Buy |
11,838,369
+3,533,237
| +43% | +$35.3M | 0.28% | 82 |
|
|
2023
Q2 | $103M | Buy |
8,305,132
+115,334
| +1% | +$1.43M | 0.24% | 110 |
|
|
2023
Q1 | $115M | Buy |
8,189,798
+2,011,683
| +33% | +$28.2M | 0.28% | 87 |
|
|
2022
Q4 | $88.4M | Buy |
6,178,115
+3,618,369
| +141% | +$51.8M | 0.23% | 113 |
|
|
2022
Q3 | $65.4M | Buy |
+2,559,746
| New | +$65.4M | 0.18% | 159 |
|
|
2022
Q1 | – | Sell |
-20,854
| Closed | -$874K | – | 2558 |
|
|
2021
Q4 | $874K | Buy |
+20,854
| New | +$874K | ﹤0.01% | 1932 |
|